Pharmaceutical Services M&A Transactions

SV Health Investors secures EpiVax, a key player in immunogenicity risk assessment for pharma and biotech, enhancing drug development efficiency.

AI safety leader Anthropic buys Coefficient Bio for $400M in stock, boosting its life sciences capabilities and drug discovery tech.

Global pharma major Lupin Limited completes acquisition of VISUfarma B.V., significantly expanding its ophthalmology portfolio and European market reach.

Cyclerion Therapeutics

Korsana Biosciences and Cyclerion Therapeutics merge, backed by $380M financing. Focus on advancing Alzheimer's drug KRSA-028 and neurodegenerative pipeline.

CapVest Partners completes €10 billion acquisition of STADA Arzneimittel AG, a leading global healthcare company, from Bain Capital and Cinven.

Biogen secures Apellis Pharmaceuticals in a $5.6 billion deal, enhancing its immunology and rare disease offerings with two approved therapies and expanding nephrology reach.

Biogen Inc. secures Apellis Pharmaceuticals for $5.6 billion, enhancing its rare disease and immunology portfolio with key therapies for kidney conditions and macular degeneration.

Columna Capital in exclusive talks to buy Evidenze for €150M. Learn about the deal, Evidenze's services, and market implications for healthcare PE.

CVC Capital Partners submits a $12.6B non-binding offer to acquire full control of Italian pharmaceutical firm Recordati, signaling a major European healthcare buyout.

CVC Capital Partners submits a €10.9 billion non-binding offer to acquire Recordati S.p.A., aiming to take the Italian pharmaceutical company private.

Sanius Health enhances its AI platform by acquiring Kielo Research, strengthening patient-centric evidence generation for life sciences innovation.

Curia

Carlyle and GTCR are reportedly exploring divestiture of Curia's Spanish pharmaceutical operations. Rothschild hired to manage potential sale of key CDMO assets.

ABE Capital Partners and Columbus Venture Partners take majority control of Sermes CRO, a Spanish contract research organization, to drive international growth.

Solabia Group, with Astorg's backing, strengthens its cosmetic ingredients and diagnostics portfolio by acquiring key divisions from SEQENS.

Alma Farmacie

Alma Farmacie, part of Pharma Green Holding, boosts its presence to 72 locations with strategic pharmacy acquisitions in Italy. Learn more about their expansion.